- Filed
- Feb 12, 2021 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2021 · Feb 12, 2021 | 13.55M sh |
| Shares Diluted | Q3 2021 · Dec 31, 2020 | 13.55M sh |
| Shares Diluted | Q3 2021 · Dec 31, 2020 | 12.91M sh |
| Shares Diluted | Q3 2021 · Dec 31, 2019 | 7.32M sh |
| Shares Diluted | Q3 2021 · Dec 31, 2019 | 7.26M sh |
| Current Liabilities | Q3 2021 · Dec 31, 2020 | $811.58K |
| Current Liabilities | Q3 2021 · Mar 31, 2020 | $1.23M |
| Total Liabilities | Q3 2021 · Dec 31, 2020 | $1.1M |
| Total Liabilities | Q3 2021 · Mar 31, 2020 | $1.73M |
| Current Assets | Q3 2021 · Dec 31, 2020 | $593.28K |
| Current Assets | Q3 2021 · Mar 31, 2020 | $175.84K |
| Total Assets | Q3 2021 · Dec 31, 2020 | $2.15M |
| Total Assets | Q3 2021 · Mar 31, 2020 | $1.64M |
| Capex | Q3 2021 · Dec 31, 2019 | $3.76K |
| Operating Cash Flow | Q3 2021 · Dec 31, 2019 | −$873.55K |
| Stockholders Equity | Q3 2021 · Dec 31, 2019 | $958.57K |
| Stockholders Equity | Q3 2021 · Sep 30, 2019 | $389.33K |
| Stockholders Equity | Q3 2021 · Jun 30, 2019 | $335.31K |
| Stockholders Equity | Q3 2021 · Mar 31, 2019 | $440.2K |
| Sga Expense | Q3 2021 · Dec 31, 2019 | $115.28K |
| Sga Expense | Q3 2021 · Dec 31, 2019 | $258.69K |
| Rd Expense | Q3 2021 · Dec 31, 2019 | $55.85K |
| Rd Expense | Q3 2021 · Dec 31, 2019 | $65.62K |
| Net Income | Q3 2021 · Dec 31, 2019 | −$556.26K |
| Net Income | Q3 2021 · Dec 31, 2019 | −$1.26M |
| Net Income | Q3 2021 · Sep 30, 2019 | −$344.76K |
| Net Income | Q3 2021 · Jun 30, 2019 | −$355.4K |
| Operating Income | Q3 2021 · Dec 31, 2019 | −$515.53K |
| Operating Income | Q3 2021 · Dec 31, 2019 | −$1.11M |
| Gross Profit | Q3 2021 · Dec 31, 2019 | −$42.31K |
| Gross Profit | Q3 2021 · Dec 31, 2019 | −$42.31K |
| Cost Of Revenue | Q3 2021 · Dec 31, 2019 | $67.87K |
| Cost Of Revenue | Q3 2021 · Dec 31, 2019 | $67.87K |
| Revenue | Q3 2021 · Dec 31, 2019 | $25.55K |
| Revenue | Q3 2021 · Dec 31, 2019 | $25.55K |